Apparent Failure of Current Intravesical Chemotherapy Prophylaxis to Influence the Long-Term Course of Superficial Transitional Cell Carcinoma of the Bladder
- 1 May 1995
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- Vol. 153 (5), 1444-1450
- https://doi.org/10.1016/s0022-5347(01)67427-5
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- INTRAVESICAL CHEMOTHERAPY AND IMMUNOTHERAPY: HOW DO WE ASSESS THEIR EFFECTIVENESS AND WHAT ARE THEIR LIMITATIONS AND USES?International Journal of Urology, 1995
- A randomised prospective study comparing intravesical instillations of mitomycin-C, BCG-Tice, and BCG-RIVM in pTa-pT1 tumours and primary carcinoma in situ of the urinary bladderEuropean Journal of Cancer, 1993
- Prophylactic Effect of aLactobacillus caseiPreparation on the Recurrence of Superficial Bladder CancerUrologia Internationalis, 1992
- A Randomized Trial of Intravesical Doxorubicin and Immunotherapy with Bacille Calmette–Guérin for Transitional-Cell Carcinoma of the BladderThe New England Journal of Medicine, 1991
- Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party)BMJ, 1988
- The Effect of Intravesical Thiotepa on the Recurrence Rate of Newly Diagnosed Superficial Bladder Cancer. An MRC StudyBJU International, 1985
- Experience with intravesical bacillus calmette-guèrin therapy of superficial bladder tumorsUrology, 1985
- Comparisons of placebo, pyridoxine, and topical thiotepa in preventing recurrence of stage I bladder cancerUrology, 1977
- Single Dose Intravesical Thiotepa as an Adjuvant to Cystodiathermy in the Treatment of Transitional Cell Bladder CarcinomaBJU International, 1976
- THIOTEPA IN THE TREATMENT OF TUMOURS OF THE BLADDERThe Lancet, 1961